Light on the brain: new study tests if infrared beams can boost focus in ADHD
NCT ID NCT07203092
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 35 times
Summary
This study tests a non-invasive light therapy called transcranial photobiomodulation (tPBM) to see if it can improve attention, memory, and brain oxygen levels in adults with ADHD. Researchers will give repeated sessions of infrared light to the forehead area and measure changes in thinking tasks and ADHD symptoms. The study involves 140 adults aged 18-44 with ADHD, whether or not they take medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas at Austin
RECRUITINGAustin, Texas, 78701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.